Imbruvica (Ibrutinib)

Ibrutinib-Imbruvica-Wholesaler

Imbruvica (Ibrutinib) Distributor

Imbruvica (Ibrutinib)  distributor wholesaler, supplier

Description:

Imbruvica (Ibrutinib) is a targeted therapy. Ibrutinib inhibits the function of Bruton’s tyrosine kinase (BTK)

 Imbruvica (Ibrutinib) Uses:

  • CLL (Chronic lymphocytic leukemia) 
  • MCL (Mantle cell lymphoma) 
  • MZL (Marginal zone lymphoma) 
  • cGVHD (Chronic graft-versus-host)
  • WM (Waldenstrom’s macroglobulinemia) 

Side Effects:

Common side effects of Imbruvica (Ibrutinib)  includes:

  • Decreased platelets
  • Diarrhea
  • Decreased neutrophils
  • Decreased hemaglobin
  • Fatigue
  • Musculoskeletal pain
  • Swelling
  • Upper respiratory tract infection
  • Nausea
  • Bruising

dosage form & Strength:

  •  Imbruvica (Ibrutinib) 140 mg Capsules wholesaler, supplier, Distributor 

Rasso Swiss Pharma is a distributor, supplier, export and wholesaler for Imbruvica (Ibrutinib).

<< Back to products